The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

Cancer is a leading cause of death in the United States and across the globe. Cancer screening is an effective preventive measure that can reduce cancer incidence and mortality. While cancer screening is integral to cancer control and prevention, due to the COVID-19 outbreak many screenings have eit...

Full description

Saved in:
Bibliographic Details
Published in:JMIR cancer 2020-10, Vol.6 (2), p.e21697-e21697
Main Authors: Cancino, Ramon S, Su, Zhaohui, Mesa, Ruben, Tomlinson, Gail E, Wang, Jing
Format: Article
Language:English
Subjects:
Breast cancer
Colorectal cancer
Coronaviruses
COVID-19
Health insurance
Low income groups
Medical diagnosis
Medical screening
Mortality
Pandemics
Prevention
Severe acute respiratory syndrome coronavirus 2
Telemedicine
Viewpoint
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer is a leading cause of death in the United States and across the globe. Cancer screening is an effective preventive measure that can reduce cancer incidence and mortality. While cancer screening is integral to cancer control and prevention, due to the COVID-19 outbreak many screenings have either been canceled or postponed, leaving a vast number of patients without access to recommended health care services. This disruption to cancer screening services may have a significant impact on patients, health care practitioners, and health systems. In this paper, we aim to offer a comprehensive view of the impact of COVID-19 on cancer screening. We present the challenges COVID-19 has exerted on patients, health care practitioners, and health systems as well as potential opportunities that could help address these challenges.
ISSN:2369-1999
2369-1999
DOI:10.2196/21697